Susquehanna International Group, LLP Lexicon Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.39 $192,978 - $305,442	-127,800 Reduced 23.01%	427,600 $671,000
Q2 2024 Aug 15, 2024	SELL	$1.54 - $2.28 $2.18 Million - $3.23 Million	-1,416,800 Reduced 71.84%	555,400 $933,000
Q1 2024 May 07, 2024	BUY	$1.3 - $3.58 $2.51 Million - $6.91 Million	1,931,000 Added 4686.89%	1,972,200 $4.73 Million
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.53 $11,200 - $17,136	-11,200 Reduced 21.37%	41,200 $63,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $42,824 - $94,132	40,400 Added 336.67%	52,400 $57,000
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.49 $163,400 - $265,240	-76,000 Reduced 86.36%	12,000 $27,000
Q1 2023 May 16, 2023	BUY	$1.99 - $2.68 $41,790 - $56,280	21,000 Added 31.34%	88,000 $213,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $61,740 - $87,808	34,300 Added 104.89%	67,000 $127,000
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $55,290 - $97,755	-28,500 Reduced 46.57%	32,700 $78,000
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $61,963 - $127,237	47,300 Added 340.29%	61,200 $114,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $75,057 - $121,352	-19,700 Reduced 58.63%	13,900 $55,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $335,972 - $531,790	-99,400 Reduced 74.74%	33,600 $162,000
Q2 2021 Aug 11, 2021	SELL	$4.12 - $5.87 $286,340 - $407,965	-69,500 Reduced 34.32%	133,000 $610,000
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $701,040 - $1.85 Million	-203,200 Reduced 50.09%	202,500 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $324,765 - $1.14 Million	309,300 Added 320.85%	405,700 $1.39 Million
Q3 2020 Nov 16, 2020	BUY	$1.44 - $2.1 $59,328 - $86,520	41,200 Added 74.64%	96,400 $139,000
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $67,900 - $89,240	-38,800 Reduced 41.28%	55,200 $110,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $278,820 - $662,972	-154,900 Reduced 62.23%	94,000 $183,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $48,348 - $78,795	15,300 Added 6.55%	248,900 $1.03 Million
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $202,440 - $1.12 Million	168,700 Added 259.94%	233,600 $703,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $188,320 - $250,272	-35,200 Reduced 35.16%	64,900 $408,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $194,456 - $354,124	44,600 Added 80.36%	100,100 $557,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $10,320 - $13,060	1,000 Added 1.83%	55,500 $592,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $259,740 - $455,877	33,300 Added 157.08%	54,500 $654,000
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $573,780 - $831,470	-73,000 Reduced 77.49%	21,200 $182,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $19,294 - $27,016	-2,200 Reduced 2.28%	94,200 $931,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $1.17 Million - $1.57 Million	96,400	96,400 $1.19 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account